Investors need to pay close attention to Addus HomeCare (ADUS) stock based on the movements in the options market lately.
While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Addus HomeCare (ADUS) came out with quarterly earnings of $1.38 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.32 per share a year ago.
Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.
DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
This Industry Outlook article features Quest Diagnostics, DaVita, Option Care Health, and Addus HomeCare.
JMP Securities initiated coverage on Addus HomeCare Corp ADUS, a provider of home-based personal care and clinical services.
Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Astrana Health, Inc. (ASTH). But which of these two stocks presents investors with the better value opportunity right now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?